Amid Strong Demand, Illumina, Inc. CEO Sees Need for More "Tuck-In" Deals

Published: Jul 25, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Shares of San Diego-based Illumina (NASDAQ: ILMN) climbed today by more than $7 a share, or roughly 10 percent, after the gene sequencing equipment maker posted quarterly results that exceeded Wall Street expectations. The stock was above $81 a share in heavy trading this afternoon. Illumina reported its seventh consecutive quarter of sequential revenue growth—driven by strong global demand for its HiSeq instruments used in genetic sequencing and related consumable supplies.

Help employers find you! Check out all the jobs and post your resume.

Back to news